← Leaderboards

Beverly Shriver Mitchell

University Of North Carolina Chapel Hill

Google Scholar ↗PubMed ↗ORCID ↗

$20,225,821

Attributed

$20,225,821

Total exposure

12

Grants

9

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.3M · FY2005–20

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$48,875,977 · 13

By mechanism

P30$40,973,162 · 7

R01$4,834,006 · 3

M01$1,559,955 · 1

T32$1,483,854 · 1

R13$25,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Programs”

David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
Sonia M Thomas · Research Triangle Institute$700,865,642
David Divins · Consortium For Ocean Leadership, Inc$609,772,544
Larry Arthur$609,313,548

Research focus

ProgramsClinical ResearchAreaResource SharingCancer CenterFundingUniversitiesPopulation SciencesBaseMemberTranslational ResearchLeadershipCancer Center Support GrantMalignant NeoplasmsFacultyAnticancer ResearchBasic ScienceStrategic PlanningCancer BiologyImmunologyMolecularDoctor Of PhilosophyPeer ReviewCancer Prevention

Grant awards (81)

DEVELOPMENTAL FUNDS (Core-002)$474,044

P30 · FY2020 · CA · contact PI

DEVELOPMENTAL FUNDS (Core-002)$472,600

P30 · FY2019 · CA · contact PI

DEVELOPMENTAL FUNDS (Core-002)$474,044

P30 · FY2018 · CA · contact PI

DEVELOPMENTAL FUNDS (Core-002)$11,296

P30 · FY2018 · CA · contact PI

DEVELOPMENTAL FUNDS (Core-002)$7,796

P30 · FY2018 · CA · contact PI

Stanford Cancer Institute$3,338,488

P30 · FY2017 · CA · contact PI

DEVELOPMENTAL FUNDS (Core-002)$356,346

P30 · FY2017 · CA · contact PI

Stanford Cancer Institute$3,345,301

P30 · FY2016 · CA · contact PI

DEVELOPMENTAL FUNDS (Core-002)$397,212

P30 · FY2016 · CA · contact PI

Stanford University Cancer Center$2,249,153

P30 · FY2015 · CA · contact PI

Stanford University Cancer Center$2,998,871

P30 · FY2014 · CA · contact PI

Stanford University Cancer Center$323,044

P30 · FY2014 · CA · contact PI

Developmental Funds$322,096

P30 · FY2014 · CA · contact PI

Project Senior Leaders$179,765

P30 · FY2014 · CA · contact PI

Stanford University Cancer Center$75,000

P30 · FY2014 · CA · contact PI

Planning and Evaluation$53,755

P30 · FY2014 · CA · contact PI

Stanford University Cancer Center$2,890,663

P30 · FY2013 · CA · contact PI

Project Senior Leaders$1,206,501

P30 · FY2013 · CA · contact PI

Developmental Funds$279,797

P30 · FY2013 · CA · contact PI

Stanford University Cancer Center$75,000

P30 · FY2013 · CA · contact PI

Planning and Evaluation$14,923

P30 · FY2013 · CA · contact PI

Stanford University Cancer Center$3,091,618

P30 · FY2012 · CA · contact PI

Project Senior Leaders$1,292,137

P30 · FY2012 · CA · contact PI

Developmental Funds$298,957

P30 · FY2012 · CA · contact PI

Developmental Funds$74,997

P30 · FY2012 · CA · contact PI

Stanford University Cancer Center$74,997

P30 · FY2012 · CA · contact PI

Planning and Evaluation$15,943

P30 · FY2012 · CA · contact PI

Stanford University Cancer Center$3,091,618

P30 · FY2011 · CA · contact PI

Project Senior Leaders$1,324,743

P30 · FY2011 · CA · contact PI

Developmental Funds$305,921

P30 · FY2011 · CA · contact PI

Stanford University Cancer Center$74,525

P30 · FY2011 · CA · contact PI

Planning and Evaluation$16,315

P30 · FY2011 · CA · contact PI

Stanford University Cancer Center$3,254,335

P30 · FY2010 · CA · contact PI

Project Senior Leaders$1,507,617

P30 · FY2010 · CA · contact PI

Cancer Stem Cells and Radiotherapy: New Approaches to Radiosensitization$801,720

P30 · FY2010 · CA · contact PI

Developmental Funds$344,341

P30 · FY2010 · CA · contact PI

Stanford University Cancer Center$126,467

P30 · FY2010 · CA · contact PI

Stanford University Cancer Center$100,000

P30 · FY2010 · CA · contact PI

Stanford University Cancer Center$99,467

P30 · FY2010 · CA · contact PI

Planning and Evaluation$18,365

P30 · FY2010 · CA · contact PI

Stanford University Cancer Center$1,611,344

P30 · FY2009 · CA · contact PI

Cancer Stem Cells and Radiotherapy: New Approaches to Radiosensitization$800,670

P30 · FY2009 · CA · contact PI

CORE--PROTOCOL-SPECIFIC RESEARCH$330,385

P30 · FY2009 · CA · contact PI

Stanford University Cancer Center$126,467

P30 · FY2009 · CA · contact PI

Stanford University Cancer Center$49,998

P30 · FY2009 · CA · contact PI

2009 AACI Annual Meeting$25,000

R13 · FY2009 · CA · contact PI

Stanford University Cancer Center$1,572,967

P30 · FY2008 · CA · contact PI

CORE--PROTOCOL-SPECIFIC RESEARCH$330,741

P30 · FY2008 · CA · contact PI

Stanford University Cancer Center$80,833

P30 · FY2008 · CA · contact PI

CORE--PROTOCOL-SPECIFIC RESEARCH$315,147

P30 · FY2007 · CA · contact PI

Inosine Monophosphate Dehydrogenase: Regulation and Function$313,972

R01 · FY2007 · CA · contact PI

Role of hPso4 in Double Strand Break Repair$226,242

R01 · FY2007 · GM · contact PI

Inosine Monophosphate Dehydrogenase: Regulation and Function$323,304

R01 · FY2006 · CA · contact PI

Role of hPso$ in Double Strand Break Repair$230,855

R01 · FY2006 · GM · contact PI

CORE--PROTOCOL-SPECIFIC RESEARCH$149,594

P30 · FY2006 · CA · contact PI

Inosine Monophosphate Dehydrogenase: Regulation and Function$308,790

R01 · FY2005 · CA

Role of hPso$ in Double Strand Break Repair$219,000

R01 · FY2005 · GM

CORE--PROTOCOL-SPECIFIC RESEARCH$145,238

P30 · FY2005 · CA

Research Fellowships in Hematology/Oncology$351,197

T32 · FY2004 · HL

NUCLEOSIDE AND NUCLEOTIDE METABOLIZING ENZYMES$326,452

R01 · FY2004 · CA

Inosine Monophosphate Dehydrogenase: Regulation and Function$308,790

R01 · FY2004 · CA

Role of hPso4 in Double Strand Break Repair$219,000

R01 · FY2004 · GM

RESEARCH FELLOWSHIPS IN HEMATOLOGY/ONCOLOGY$343,421

T32 · FY2003 · HL

NUCLEOSIDE AND NUCLEOTIDE METABOLIZING ENZYMES$326,452

R01 · FY2003 · CA

Inosine Monophosphate Dehydrogenase: Regulation/Function$306,196

R01 · FY2003 · CA

NUCLEOSIDE AND NUCLEOTIDE METABOLIZING ENZYMES$326,452

R01 · FY2002 · CA

RESEARCH FELLOWSHIPS IN HEMATOLOGY/ONCOLOGY$320,216

T32 · FY2002 · HL

INOSINE MONOPHOSPHATE DEHYDROGENASE--REG AND FUNCTION$255,714

R01 · FY2002 · CA

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$190,747

M01 · FY2002 · RR

NUCLEOSIDE AND NUCLEOTIDE METABOLIZING ENZYMES$325,987

R01 · FY2001 · CA

RESEARCH FELLOWSHIPS IN HEMATOLOGY/ONCOLOGY$306,738

T32 · FY2001 · HL

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$294,555

M01 · FY2001 · RR

INOSINE MONOPHOSPHATE DEHYDROGENASE--REG AND FUNCTION$249,369

R01 · FY2001 · CA

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$190,747

M01 · FY2001 · RR

NUCLEOSIDE AND NUCLEOTIDE METABOLIZING ENZYMES$324,223

R01 · FY2000 · CA

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$294,555

M01 · FY2000 · RR

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$294,555

M01 · FY2000 · RR

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$294,555

M01 · FY2000 · RR

INOSINE MONOPHOSPHATE DEHYDROGENASE--REG AND FUNCTION$243,208

R01 · FY2000 · CA

RESEARCH FELLOWSHIPS IN HEMATOLOGY/ONCOLOGY$162,282

T32 · FY2000 · HL

REFRACTORY HEMATOLOGIC MALIGNANCIES (COMPOUND 506)$241

M01 · FY2000 · RR